The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

被引：0
|
作者：
Sheliyan Raveenthiran
John Yaxley
Troy Gianduzzo
Boon Kua
Louise McEwan
David Wong
Gail Tsang
James MacKean
机构：
[1] Royal Brisbane and Women’s Hospital,Department of Medicine
[2] Wesley Urology Clinic,undefined
[3] University of Queensland,undefined
[4] Brisbane Prostate Clinic,undefined
[5] Wesley Medical Imaging,undefined
[6] Genesis Cancer Care,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 390
页数：5
相关论文
共 50 条
  • [21] Ga-68-PSMA PET/CT for Prostate Cancer
    Hellwig, D.
    Moosbauer, J.
    Eilles, C.
    AKTUELLE UROLOGIE, 2014, 45 (06) : 457 - 463
  • [22] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [23] The Value of Ga-68 PSMA PET /CT in Primary Staging of Prostate Cancer
    Ayan, Asli
    Alkan, Sumeyye
    Gunalp, Bengul
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [24] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [25] 68Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer
    Davies, Amy
    Foo, Marcus
    Gan, Chun Loo
    Kourambas, John
    Redgrave, Nicholas
    Donnellan, Scott
    Appu, Sree
    Williams, Scott
    Coleman, Andrew
    Segelov, Eva
    Bradley, Jason
    Soo, Geoffrey
    Ramdave, Shakher
    Kwan, Edmond M.
    Azad, Arun A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E204 - E210
  • [26] Re: The role of 68Ga-PSMA-PET/CT in radiotherapy planning in prostate cancer
    Cihan, Yasemin Benderli
    INTERNATIONAL BRAZ J UROL, 2019, 45 (04): : 863 - 865
  • [27] Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
    Onal, Cem
    Torun, Nese
    Akyol, Fadil
    Guler, Ozan Cem
    Hurmuz, Pervin
    Yildirim, Berna Akkus
    Caglar, Meltem
    Reyhan, Mehmet
    Ozyigit, Gokhan
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : E510 - E516
  • [28] 68-Ga-PSMA-PET in the diagnosis of local recurrent disease after radiotherapy in patients with prostate cancer.
    Pfister, David
    Schmidt, Matthias
    Kohl, Tobias
    Porres-Knoblauch, Daniel
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] 68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
    Zohar Keidar
    Ronit Gill
    Elinor Goshen
    Ora Israel
    Tima Davidson
    Maryna Morgulis
    Natalia Pirmisashvili
    Simona Ben-Haim
    Cancer Imaging, 18
  • [30] 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls
    Keidar, Zohar
    Gill, Ronit
    Goshen, Elinor
    Israel, Ora
    Davidson, Tima
    Morgulis, Maryna
    Pirmisashvili, Natalia
    Ben-Haim, Simona
    CANCER IMAGING, 2018, 18
12345